Shortsand longs performed comparably for the year

is a biopharmaceutical company with unique protein processdevelopment and manufacturing experience and a proprietary protein platformaimed at niche markets with unmet medical needs. For more information, pleasevisit http:// Forward-Looking StatementsThis release contains forward-looking statements which are made pursuant toprovisions of Section 21E of the Securities Exchange Act of 1934. Investorsare cautioned that such statements in this release, including statementsrelating to planned clinical study design, regulatory and business strategies,plans and objectives of management and growth opportunities for existing orproposed products, constitute forward-looking statements which involve risksand uncertainties that could cause actual results to differ materially fromthose anticipated by the forward-looking statements. The risks anduncertainties include, without limitation, risks that product candidates mayfail in the clinic or may not be successfully marketed or manufactured, we maylack financial resources to complete development of product candidates, theFDA may interpret the results of studies differently than us, competingproducts may be more successful, demand for new pharmaceutical products maydecrease, the biopharmaceutical industry may experience negative markettrends, our entrance into the follow on biologics market may be unsuccessful,our common stock could be delisted from the Nasdaq Capital Market and otherrisks and challenges detailed in our filings with the U.S. Readers are cautioned not to place undue reliance onany forward-looking statements which speak only as of the date of thisrelease. We undertake no obligation to publicly release the results of anyrevisions to these forward-looking statements that may be made to reflectevents or circumstances that occur after the date of this release or toreflect the occurrence of unanticipated events. Investor Relations Contact:Brian Ritchie - Media Contact:Irma Gomez-Dib - SOURCEInsmed Inc.Investor Relations, Brian Ritchie, 1-212-850-5683, , ormedia, Irma Gomez-Dib, 1-212-850-5761, , both of FD forInsmed; or Jan Borg, CEO of Premacure AB, .

Johnson School MBA Student-Run Hedge Fund Beats Market, Manages Risk to YieldPositive ReturnsFund Returns 0.42 for 2008, Down 1.29 in Fourth QuarterITHACA, N.Y., Jan. In the context of this turbulent environment, the Cayuga Fund's performancewas strong, driven primarily by a prudent risk management strategy.Shortsand longs performed comparably for the year.Returning 65 percent for the quarter, one of the best long performers for thequarter was Yanzhou Coal Mining Company (YCZ).Based in China, the company isinvolved in the mining, preparing, transportation, and sale of coal.Thestock's performance has largely been driven by the growing global demand forinexpensive sources of energy.One of the best short performers was American Apparel (APP), generating areturn of 76 percent for the fund in the quarter.The company manufactures,distributes, and retails casual wear apparel for men, women, and children. Like most retailers, the company has suffered from negative sector sentiment. Though it has performed well relative to many of its peers, student managersbelieve the macro environment for retailers is too negative to overcome in thenear future.According to Andy Herr (MBA '09), investment relations representative for theCayuga Fund, "In spite of governmental efforts to prop up the financialindustry and by extension, the equity markets, the economic picture remainsvery challenging and we expect this trend to continue throughout 2009.TheCayuga Fund intends to remain focused on generating absolute return through acombination of selective stock-picking and prudent risk management."The Cayuga MBA Fund is an investment vehicle that aims to provide acompetitive rate of risk-adjusted return to its investors while enhancing theeducational and professional opportunities of Cornell's Johnson School MBAstudents.It is supported by the analytical platform of the Parker Center,cutting-edge research by faculty members, and extensive participation bystudent portfolio managers.The Parker Center is a classroom providingreal-time stock quotes, international data feeds, and financial analysissoftware and data valued at more than $1.8 million per year in licensing feesand comparable, if not better, than the resources found at many Wall Streetfirms.The Cayuga MBA Fund is managed by 32 portfolio managers, including twoquantitative analysts, a trader, and an investor relations manager who, underthe guidance of faculty and outside investment advisors, work to fulfill theinvestment objective of the fund to achieve consistent positive returns thatare uncorrelated with equity market benchmarks, and to maintain significantlylower volatility than the broader market.More information on the Cayuga Fund and the Parker Center can be found onlineat: http:// the Johnson SchoolFounded in 1946, the Johnson School is Cornell University's graduate school ofmanagement. Consistently ranked as one of the top graduate schools ofbusiness, the Johnson School builds upon Cornell's depth and breadth ofdistinguished research and teaching, and its vast, worldwide network ofalumni, faculty, and colleagues. The school's "performance learning" approachoffers students defined frameworks and analytical tools, combined with expertfeedback to solve real problems in real organizations. Deliberately small andextremely selective, the Johnson School maintains an intense, collaborativecommunity, where students develop teamwork and networking skills that fosterinnovation and deliver results.

Programs include one- and two-year MBAdegrees, an Executive MBA and the Cornell-Queen's Executive MBA, which offersinteractive videoconferencing sessions across the U.S. and Canada.For moreabout the Johnson School please visit: Topic Expert(s): For information on the listed expert(s), clickappropriate link:Sanjeev Bhojraj Associate Professor, Cayuga Fund Faculty Director Johnson School at Cornell UniversityDeirdre G. ) Ok, I'm definitely not feeling right at the moment. I'm actually keeping up with a team's season preview, something has to be wrong with me. This is one of the few times I've posted a team's preview the day it was supposed to be previewed.

So without further delay, here comes your 2009-2010 Washington Wizards season preview.Washington Wizards- The Washington Wizards had a very miserable year last year. After being predicted as a playoff contender, injuries resulted in a 19-63 record.- During the off-season the Wizards picked up some very good role players They added Mike Miller, Randy Foye, and Fabricio Oberto. - With Caron Butler, Gilbert Arenas, Antawan Jamison, and DeShawn Stevenson this team should not have a problem putting up points. - The team's biggest weakness is the injuries this team seems to deal with every year. If they get matched up against the Cavs you never know what could happen, given their success against Cleveland.Prediction: 44-38 (I think a few injuries will slow this team during the regular season)For full previews check out: Bullets Forever Truth About It Hoops Addict. State of North Carolina Department of Revenue Selects Oracle(R) EnterpriseTaxation Management to Deliver Enhanced Taxpayer ServiceREDWOOD SHORES, Calif., Jan.